High‐dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high‐risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor
Pediatric Blood & Cancer2006Vol. 48(4), pp. 408–415
Citations Over TimeTop 17% of 2006 papers
Ki Woong Sung, Keon Hee Yoo, Eun Joo Cho, Hong Hoe Koo, Do Hoon Lim, Hyung Jin Shin, Seung Do Ahn, Young Seob Shin, Eun Seok Choi, Thad T. Ghim
Abstract
High-dose chemotherapy may improve the survival of children with newly diagnosed high-risk MB/sPNET, and, to some extent, the survival of those with relapsed MB/sPNET. Further study is necessary to elucidate the efficacy of tandem double HDCT.
Related Papers
- → Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa(1990)91 cited
- → Medulloblastoma/Primitive Neuroectodermal Tumor in 45 Adults(1995)54 cited
- → Atypical teratoid/rhabdoid tumors(2003)45 cited
- → PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors(2004)22 cited
- → Primitive neuroectodermal tumors/medulloblastoma(2002)6 cited